Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1998
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998EP0879600A1 Fructan containing composition for the prevention and treatment of colon cancer
11/25/1998EP0879288A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
11/25/1998EP0879282A1 Immunotherapy using cytotoxic t lymphocytes (ctl)
11/25/1998EP0879281A2 Methods and compositions for transforming dendritic cells and activating t cells
11/25/1998EP0879280A1 A method for selectively purging cd77?+ cells from bone marrow
11/25/1998EP0879241A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor
11/25/1998EP0879240A1 Human criptin growth factor
11/25/1998EP0879227A1 Tyrosin-derivate as alpha-v-integrin inhibitors
11/25/1998EP0879223A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/25/1998EP0833636A4 Method for inhibiting neoplastic disease in mammals
11/25/1998EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998EP0621773B1 Formulation and use of carotenoids in treatment of cancer
11/25/1998EP0620004B1 Medicinal composition
11/25/1998EP0601043B1 Hybrid cytokines
11/25/1998CN1199738A Ribosome deactivating protein originating from octagon towel gourd
11/25/1998CN1199613A Preparation having increased in vivo tolerability
11/25/1998CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process
11/24/1998US5840974 Metalloproteinase inhibitors
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840931 Antitumor agents
11/24/1998US5840925 Trioxane dimer compounds having antiproliferative and antitumor activities
11/24/1998US5840918 Isoprenyl transferase inhibitors
11/24/1998US5840911 Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors
11/24/1998US5840898 Method of removing heavy metal contaminants from organic compounds
11/24/1998US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer
11/24/1998US5840860 Delivering fatty acid to colon by linking fatty acid to a carbohydrate carrier
11/24/1998US5840842 Receptor-type phosphotyrosine phosphatase-sigma
11/24/1998US5840840 Selective RNase cytotoxic reagents
11/24/1998US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
11/24/1998US5840761 Antiarrhythmia agents, inhibitors of the cellular na+/h+ antiporter
11/24/1998US5840750 Discodermolide compounds
11/24/1998US5840745 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
11/24/1998US5840742 Pharmaceutical composition for inhibiting the growth of cancers
11/24/1998US5840735 Estrogen
11/24/1998US5840721 Imidazole derivatives as MDR modulators
11/24/1998US5840713 Therapy for tissue membrane insufficiency
11/24/1998US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998US5840693 Vascular endothelial growth factor-B
11/24/1998US5840687 Polypeptides for kinases
11/24/1998US5840682 Peptide antagonists of neurotensin
11/24/1998US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors
11/24/1998US5840569 Human GTP-binding proteins
11/24/1998US5840559 Isolated and purified polynucleotide sequence coding polypeptide; hybridization probes; vectors and host cells for gene expression; anticancer and antitumor agents
11/24/1998US5840544 DNA encoding rantes homolog from prostate
11/24/1998US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998US5840514 Using a fibronectin-depleted substrate and peptide invasion-inducing agent
11/24/1998US5840505 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells
11/24/1998US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity
11/24/1998US5840317 Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840296 Engineered cytotoxic ribonuclease A
11/24/1998CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/19/1998WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051793A1 Apo-2 RECEPTOR
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051703A1 20(s) camptothecin glycoconjugates
11/19/1998WO1998051702A1 Methods and compositions for destruction of selected proteins
11/19/1998WO1998051669A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
11/19/1998WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051304A1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer
11/19/1998WO1998051303A1 Hiv and cancer treatment
11/19/1998WO1998051294A2 Method and composition for treating cancers
11/19/1998WO1998051293A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma
11/19/1998WO1998040483A3 28 human secreted proteins
11/19/1998WO1998040058A3 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998CA2291436A1 20(s) camptothecin glycoconjugates
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2289686A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma
11/19/1998CA2289684A1 Method and composition for treating cancers
11/19/1998CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287911A1 Apo-2 receptor
11/19/1998CA2286875A1 Chemical compounds
11/19/1998CA2268848A1 Hiv and cancer treatment
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
1 ... 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 ... 2211